Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Pediatric T-cell prolymphocytic leukemia with an isolated 12(p13) deletion and aberrant CD117 expression.

Bellone M, Svensson AM, Zaslav AL, Spitzer S, Golightly M, Celiker M, Hu Y, Ma Y, Ahmed T.

Exp Hematol Oncol. 2012 Apr 18;1(1):7. doi: 10.1186/2162-3619-1-7.

2.

Do novo del(9)(p13) in a childhood T-cell prolymphocytic leukemia as sole abnormality.

Wafa A, Aljapawe A, Othman MA, Liehr T, Alhourani E, Al Achkar W.

Exp Hematol Oncol. 2014 Nov 25;3:28. doi: 10.1186/2162-3619-3-28. eCollection 2014.

3.

T-cell prolymphocytic leukemia (T-PLL) with overlapping cytomorphological features with T-CLL and T-ALL: a case initially diagnosed by fine-needle aspiration cytology and immunocytochemistry.

Das DK, Pathan SK, Joneja M, Al-Musawi FA, John B, Mirza KR.

Diagn Cytopathol. 2013 Apr;41(4):360-5. doi: 10.1002/dc.21781. Epub 2011 Oct 11.

PMID:
21987484
4.

A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.

Figueroa-Jiménez LA, Cabrera-Márquez AL, Báez-Díaz L, Cáceres-Perkins W.

Bisturi (S Juan). 2016 Mar-Jun;2016:12-16.

5.

A pediatric case of T-cell prolymphocytic leukemia.

Mitton B, Coutre S, Willert J, Schlis K, Porteus M, Kharbanda S, Agarwal-Hashmi R.

Pediatr Blood Cancer. 2015 Jun;62(6):1061-2. doi: 10.1002/pbc.25336. Epub 2014 Nov 21.

PMID:
25417638
6.

T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.

Sugimoto T, Imoto S, Matsuo Y, Kojima K, Yasukawa M, Murayama T, Kohfuku J, Mizuno I, Yakushijin K, Sada A, Nishimura R, Koizumi T.

Ann Hematol. 2001 Dec;80(12):749-51. Epub 2001 Oct 13.

PMID:
11797117
7.

T- cell prolymphocytic leukemia - a rare case.

Ghosh S, Advani SH.

Indian J Cancer. 2005 Apr-Jun;42(2):104-6.

8.

[T-cell prolymphocytic leukemia: potential diagnostic pitfalls].

Dessart P, Lemaire P, Le Dû K, Sandrini J, Prophette B, Maillard H.

Ann Dermatol Venereol. 2014 Dec;141(12):777-81. doi: 10.1016/j.annder.2014.09.012. Epub 2014 Oct 23. Review. French.

PMID:
25433931
9.

Prolymphocytic leukaemia and Hodgkin's lymphoma.

Naranjo TA, Matutes El El, Martínez JJ, Font Ferré L, Domingo A, Príncep RB, Usach TS.

Eur J Haematol. 2002 Sep;69(3):182-4.

PMID:
12406013
10.

T cell-prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence: a case report.

Singhal M, Raina V, Gupta R, Das P.

Cases J. 2010 Jan 4;3:4. doi: 10.1186/1757-1626-3-4.

11.

T-cell prolymphocytic leukemia: a report of two cases with review of literature.

Naseem S, Gupta R, Kashyap R, Nityanand S.

Indian J Hematol Blood Transfus. 2008 Dec;24(4):178-81. doi: 10.1007/s12288-008-0043-6. Epub 2009 Jan 11.

12.

A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.

Paul RN, Alizadeh L, Ajayi OI, Karpurapu H, Ganesan C, Taddesse-Heath L, Aggarwal A.

Acta Haematol. 2012;127(4):235-43. doi: 10.1159/000336241. Epub 2012 Apr 13. Review.

PMID:
22517037
13.

Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation.

Collins RH, Piñeiro LA, Agura ED, Fay JW.

Bone Marrow Transplant. 1998 Mar;21(6):627-8.

14.

[Cerebriform variant type of T cell prolymphocytic leukemia: Report of one case].

Peña C, Valladares X, Soto C, Encina A, Marinov N, Undurraga MS, Cabrera ME.

Rev Med Chil. 2016 Jan;144(1):124-8. doi: 10.4067/S0034-98872016000100016. Spanish.

15.

[Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].

Maeda A, Iwai K, Ishibashi T.

Rinsho Ketsueki. 2009 Aug;50(8):658-62. Japanese.

PMID:
19915381
16.

Small Cell Variant of T-Cell Prolymphocytic Leukemia with Acquired Palmoplantar Keratoderma and Cutaneous Infiltration.

Al-Musalhi B, Shehata N, Billick R.

Oman Med J. 2016 Jan;31(1):73-6. doi: 10.5001/omj.2016.14.

17.

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.

Hopfinger G, Busch R, Pflug N, Weit N, Westermann A, Fink AM, Cramer P, Reinart N, Winkler D, Fingerle-Rowson G, Stilgenbauer S, Döhner H, Kandler G, Eichhorst B, Hallek M, Herling M.

Cancer. 2013 Jun 15;119(12):2258-67. doi: 10.1002/cncr.27972. Epub 2013 Mar 19.

18.

Infiltration of the thyroid gland by T-cell prolymphocytic leukemia.

Fujiwara K, Fukuhara T, Kitano H, Okazaki T.

Thyroid. 2014 Aug;24(8):1314-8. doi: 10.1089/thy.2013.0462. Epub 2014 Jun 18.

PMID:
24762052
19.
20.

T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.

Magro CM, Morrison CD, Heerema N, Porcu P, Sroa N, Deng AC.

J Am Acad Dermatol. 2006 Sep;55(3):467-77.

PMID:
16908353

Supplemental Content

Support Center